During intestinal transplantation, venous access is crucial for administration of blood, fluid, medications, and for haemodynamic monitoring. 8 When veins of both the upper and the lower body are compromised, the options for vascular access are limited; a plan for establishing sufficient vascular access in the operating theatre is critical to prevent prolonging the cold ischaemic time of donor organs. 9 Therefore, it is important to have a comprehensive evaluation of the venous system, 10 and establish a strategy for alternative vascular access (AVA) for these patients.
of venous obstruction in adult patients who presented for intestinal transplantation, and to review the variations of vascular access and the outcomes when AVA is utilized.
Methods
The study was approved by the local institutional review board (#308029). The requirement for written informed consent was waived by the institutional review board.
Study population
The retrospective chart review was performed on adult patients (age .18 yr) who underwent primary intestinal transplantation during a 9 yr period (January 1, 2001 -December 31, 2009) in a single institution. In this study, 'intestinal transplantation' included isolated small bowel transplantation, small bowel and liver transplantation, modified multi-visceral transplantation (small bowel, stomach, duodenum, and pancreas), and multi-visceral transplantation (small bowel, stomach, duodenum, pancreas, and liver). Only the patients who had preoperative contrast venography (VG) were included in the analysis.
Contrast venography
Before 2004, duplex ultrasonography was performed as the screening method and VG was performed selectively. 1 However, institutional policy has been changed and VG is now performed before operation on all candidates to evaluate central venous system patency. 12 19 Each vessel was classified as either patent or with obstruction/stenosis; the latter was diagnosed when more than 50% decrease of the diameter relative to the adjacent normal vessel was observed. The following central veins were evaluated: bilateral internal jugular veins (IJVs), bilateral subclavian veins (SCVs), bilateral brachiocephalic veins (BCVs), bilateral iliac -femoral veins, the superior vena cava (SVC), and the inferior vena cava (IVC). The existing TPN catheter was left in place, and the vessel was examined using a contrast dye injection via a newly established peripheral venous line with the same VG classification.
Other modalities, such as magnetic resonance and computer tomography, were not performed to evaluate venous obstruction in this series, although they may have been performed to evaluate other concurrent conditions.
Anaesthetic management and vascular access
Multi-disciplinary evaluation was performed before operation on all patients. VG was reviewed and the strategy for vascular access was determined. If there was no abnormality (either obstruction or stenosis) in the upper body venous system (SVC, or bilateral BCVs, or bilateral IJVs and bilateral SCVs), the patients received percutaneous insertion of a large cannula via the upper body central venous system (category I). If there was abnormality in the upper body venous system, while there was no abnormality in the lower body venous system [IVC or bilateral femoral (and/or external iliac) veins], the patients received percutaneous insertion of a large cannula via the femoral veins (category II). If there was abnormality in both the upper body venous system and the lower body venous system, vascular access had to be established by surgical cut-down, by interventional radiology, or with non-venous access (category III). Vascular accesses established in categories II and III were defined as AVA.
The standard anaesthetic management has been detailed elsewhere. 20 After induction of general anaesthesia using peripheral venous access or venous access established before operation, two arterial catheters (one in the radial artery and the other in the femoral artery) and a transoesophageal echocardiography probe were placed for haemodynamic monitoring. Two large-bore i.v. lines (8.5-9.0 Fr) were established percutaneously; a pulmonary arterial catheter was placed when possible. The upper body central venous system (either via the jugular veins or the SCVs) was preferred. The lower body venous system (the femoral veins) was used when venous access in the upper body was considered to be inadequate. None of the existing indwelling catheters for TPN was replaced with a large-bore catheter for transplantation.
Protocol of AVA using intra-arterial and intra-osseous techniques
Since 2004, a new institutional protocol has been established and approved as part of AVA strategy for intestinal transplant recipients. Intra-arterial and intra-osseous catheters are used as the main volume lines until creation of a surgical venous access in the abdomen. 12 Intra-arterial access was accomplished with percutaneous insertion of an 8. The arterial pressure was monitored via both catheters and the lower extremities were monitored with pulse oximeters. Through the arterial lines, crystalloids, blood products, and a limited number of medications were infused as needed. 21 22 Intra-osseous access was secured at the distal tibia with an intra-osseous device (EZ-IO, Vidacare, Co., San Antonio, TX, USA). 12 23 Intra-arterial and intra-osseous accesses are considered to be temporary accesses placed to prevent exsanguination during the dissection phase of the intestinal transplantation. Upon the completion of the dissection, intra-abdominal vessels (i.e. the ovarian vein or the inferior mesenteric vein) were exposed; a venous catheter (Bard Hickman 12 Fr Dual-Lumen CV catheter, Bard Access Systems, Inc., Salt Lake City, UT, USA) was tunnelled through the right abdominal wall and placed with cut-down technique into the vein. An elastic band placed around the vein secured the catheter and automatically ligated the vein permitting catheter removal in the remote postoperative period without surgical re-exploration. After adequate surgically created venous lines were established, they are used in preference to the arterial and intra-osseous infusion lines. At the end of operation, the intra-arterial and intra-osseous lines were removed in the operating theatre as indicated.
Transplantation procedure
The surgical techniques for intestinal transplantation have been previously described in detail. 24 -26 In nearly half of the isolated small bowel transplant recipients, venous outflow was connected to a systemic venous system rather than to a portal venous system. This necessitated partial or complete clamping of the IVC during the vascular anastomosis.
Data collected

Perioperative information
Preoperative data included characteristics of the recipients (age, gender, BMI, race, the diagnosis for organ failure), duration of TPN support, and co-morbidities, including liver dysfunction (liver cirrhosis requiring liver transplantation), respiratory dysfunction (chronic obstructive pulmonary disease, asthma, sleep apnoea syndrome, dyspnoea due to thoracic effusion), cardiac disease (systemic hypertension, coronary artery disease, congestive heart failure), hypercoagulable state, 27 28 history of DVT, placement of the IVC filter, diabetes mellitus, and renal failure. Recent history of catheter-related infection (within 1 month before the transplantation) was also included. Intraoperative data included time required for line insertion after induction of general anaesthesia, duration of transplantation, amount of blood transfusion required, and intraoperative requirement of vasoactive agents.
Postoperative data included days required for weaning off TPN, intensive care unit stay, and patient and graft survival rates at 30 days, at 1 yr, and at 3 yr.
Venous obstruction/stenosis
Based on preoperative VG examination, the venous systems (SVC, IVC, BCVs, IJVs, SCVs, iliac -femoral veins) were labelled as either patent or obstructed/stenosed.
Alternative vascular access
Vascular accesses for transplantation were identified on the anaesthesia record. The patients who underwent transplantation without AVA (category I) were termed the non-AVA group, while the patients who required AVA for transplantation (categories II and III) were termed the AVA group. Perioperative data and outcomes were compared between these two groups. 
Statistical analysis
Results
Of the 220 adult patients who underwent primary intestinal transplantation, 173 patients (78.6%) were included in the study and 47 patients (21.4%) were excluded. Thirty-nine patients were excluded for not having received preoperative contrast venography (VG) and eight patients were excluded for having incomplete records. VG was not performed in 39 patients because of negative findings for obstruction/stenosis with duplex ultrasonography in 15 patients (all were performed before 2004), contrast dye allergy in 13, poor medical condition in four, difficult venous access in two, and unknown factors in five. Of note, all of the 47 excluded patients underwent intestinal transplantation without AVA.
Preoperative patient characteristics
The majority of patients (103: 58%) were women. The mean age was 43 (12) yr. Thrombosis of the superior mesenteric vessels was the most common aetiology of small intestine loss (58 patients: 34%), followed by Crohn's disease (42 patients: 24%) and post-gastric bypass surgery/ pseudo-obstruction (36 patients: 21%). The median duration of TPN was 36 months (0 -312 months); 160 cases (93%) were TPN-dependent. Co-morbidities were found in 105 (61%) patients, including end-stage liver disease in 67 (39%), hypercoagulable state in 37 (21%), respiratory dysfunction in 31 (18%), deep venous thrombosis (DVT) in 28 (16%), existence of IVC filter in 27 (16%), diabetes mellitus in 27 (16%), systemic hypertension in 26 (15%), coronary artery disease in 22 (13%), and renal insufficiency requiring dialysis in 13 (8%).
Preoperative evaluation with VG
VG showed only 18% (32 patients of 173) were free from central venous obstruction/stenosis (Table 1 ). In the upper body venous system, the left IJV had the highest incidence of obstruction/stenosis (69 patients: 42%), followed by the right SCV (66 patients: 40%). The SVC was abnormal in 13 patients (8%) and obstructed in six (4%). In the lower body venous system, the left iliac vein had the highest incidence (29 patients: 17%) of abnormality. The IVC was abnormal in seven patients (4%) and obstructed in three patients (2%).
Intraoperative data
In 71 patients (41%), a liver graft was concurrently transplanted ( Table 2 ). The average surgical time was 12.8 h.
One hundred and fifty patients (87%) received a peripheral venous line before entering the operating theatre. The other 23 patients had central lines placed before operation, including one patient with percutaneous access to the hepatic vein. A total of 115 patients had a peripherally inserted central catheter via the brachial vein.
The average time the anaesthesiology team spent placing vascular accesses after induction of anaesthesia was 109 min.
Alternative vascular access
In category I patients (95.4%, 165 patients), central venous lines were secured via the IJVs in 91.3% (158 patients), while they were placed via the SCVs or the EJVs in 4.0% (seven patients).
AVA was required in a total of 4.6% (eight patients): category II in 2.3% (four patients) and category III in 2.3% (four patients) ( Table 3) . Intra-arterial infusion lines were placed in four patients (2.3%), all of whom were category III. The intra-arterial lines were used for fluid administration in two cases, while the lines were kept on 'stand-by' in the other two. No complication related to the placement and use of the intra-arterial lines was observed.
Preoperative risk factors for venous obstruction/ stenosis and risk factors for requiring AVA None of the clinical factors was significantly different between the patients with and without venous obstruction/ stenosis in univariate analysis (Table 4) .
Hypercoagulable state and the existence of preoperative IVC filter were identified more frequently in the AVA group than in the non-AVA group. Multivariate analysis was not performed due to the small number of events (i.e. AVA).
Outcomes of patients with venous obstruction/ stenosis and of patients requiring AVA
Intraoperative parameters and postoperative outcomes were compared (i) between patients with venous obstruction/stenosis and those without; and (ii) between the AVA group and the non-AVA group (Table 5 ). In the former comparison, no significant differences were found. In the latter comparison, the incidence of intraoperative hypotension was significantly higher in the AVA group. The time required 24.5%, and thrombosis of all six vessels in 1.9%. 1 Our incidence of venous abnormality was higher, mainly due to our inclusion of additional veins (bilateral BCVs, the SVC, and the IVC), the use of VG, and our inclusion of stenosis. Our findings confirm the importance of preoperative examination of the venous system in this patent population. VG is regarded as a reliable test to detect central vein obstruction. 29 Although we acknowledge the usefulness of duplex ultrasonography as a non-invasive screening tool, 1 VG has demonstrated a better specificity and sensitivity over duplex ultrasonography and allowed examination of the BCVs, the SVC, and the IVC. 19 Selvaggi and colleagues 1 found one paediatric patient with SVC thrombosis who presented no thrombosed vessels under duplex ultrasonography.
The clinical significance of central venous obstruction/ stenosis is determined by the anticipated use of the i.v. line. Veins feeding into collateral networks surrounding a thrombosed central vein can be used for infusion of small volumes under low pressure; however, they are not reliable for rapid replacement of lost blood, haemodynamic monitoring, and instillation of potent medications. A new classification system was used to address the usable vascular access (Fig. 1) . First, we identified patients with accessible veins in the upper body, accomplished with standard percutaneous methods as category I. In this group, transfusion of blood, infusion of medications, and reliable invasive haemodynamic monitoring was possible, even if temporary occlusion of the IVC was necessary during surgery. Secondly, we identified patients in whom venous occlusions prevented the use of the upper body for transfusion or haemodynamic monitoring but in whom lower extremity venous access for transfusion was possible, so long as the surgery did not require clamping of the IVC. In these patients, haemodynamic monitoring relied heavily upon transoesophageal echocardiography. In this particular transplantation procedure where IVC manipulation is often necessary and potential blood loss in the IVC system is anticipated, this approach should be classified as AVA. Lastly, patients who require special techniques to establish vascular accesses that may not be available in a timely fashion are defined as category III. This category requires advanced planning for surgical techniques or interventional radiology. Several investigators reported various AVA strategies, including azygos vein central catheter insertion, 15 16 trans-hepatic venous catheters, 1 16 direct intra-atrial catheter via midline sternotomy, 16 and direct puncture of SVC stump 16 or the left renal vein. 17 Radiographic re-canalization techniques should be categorized as AVA. 1 11 16 Intra-arterial infusion was indicated for our patients in category III; only for this category of patients, we considered potential benefits of the intra-arterial infusion method outweighed the potential risk associated with the method. The use of the arterial system as an alternative blood transfusion route has been demonstrated since the 1940s. 30 31 A largebore cannula can be placed in the femoral arteries to accommodate fluid and blood administration with acceptable risk if the indication is strong. 12 It should be stressed that the nonvenous vascular accesses, including intra-osseous access, should be considered as bridges to venous access secured in the surgical field. Identification of the risk factors for venous obstruction/ stenosis and for the requirement of AVA was attempted, respectively. In the former analysis, none of the clinical factors was identified as such. In the latter analysis, the AVA group had a significantly higher incidence of Outcomes of patients who had venous obstruction/stenosis or who required AVA were comparable with those without each condition. This finding indicates that those with severely thrombosed venous system should not be excluded from candidacy for intestinal transplantation. In the AVA group, the time required for line placement after induction of anaesthesia did not increase. Time was not wasted in futile attempts to place venous lines in patients known to lack accessible central veins in the upper body.
There are several limitations in this study. First, 47 patients (21.4%) out of 220 who underwent intestinal transplantation were excluded from analysis due to the lack of VG. Since none of these excluded cases required AVA for transplantation, incidence of the patients requiring AVA would be lower than the final calculation (eight out of 220 yielded 3.6%). Secondly, this study did not include the paediatric population.
In conclusion, adult patients undergoing intestinal transplantation carry a high incidence of central venous obstruction/stenosis; therefore, preoperative screening using VG is crucial and a strategy should be established to manage difficult venous access with AVA. The new classification system for vascular access in intestinal transplantation would improve communication among the transplant community.
